Targeting transcription factors for plant disease resistance: shifting paradigm

被引:15
|
作者
Chattopadhyay, Anirudha [1 ]
Purohit, Jyotika [1 ]
Tiwari, Kapil K. [2 ]
Deshmukh, Rupesh [3 ]
机构
[1] SD Agr Univ, Dept Plant Pathol, Sk Nagar 385506, India
[2] SD Agr Univ, Biosci Res Ctr, Sk Nagar 385506, India
[3] Natl Agrifood Biotechnol Inst, Mohali 140306, India
来源
CURRENT SCIENCE | 2019年 / 117卷 / 10期
关键词
Transcription factors; plant defence; peptide interference; synthetic promoters; gene expression; INDUCED SYSTEMIC RESISTANCE; ARTIFICIAL MICRORNAS; NEGATIVE REGULATORS; DEFENSE RESPONSES; BASAL RESISTANCE; GENE; CRISPR/CAS9; EXPRESSION; BACTERIAL; ACCUMULATION;
D O I
10.18520/cs/v117/i10/1598-1607
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Transcription factors (TFs) are regulatory proteins that have the ability to alter targeted gene expression either solely by themselves or as a part of the protein complex. Many such TFs have significant regulatory role in plant defence. Being master switches for gene regulation, they become the unique candidates for targeting functional hub and dynamic networks and nodes of different defence signalling pathways in plant. Of many approaches transgenic overexpression or down-regulation of TFs is widely adopted, mainly to characterize their vital role in disease resistance; however their practical utilization remains limited in breeding programmes. Alternatively, exogenous application of synthetic chemicals/biocontrol agents is also efficient to regulate their expression, but not successful in the field. Hence, the focus has now shifted towards synthetic promoters (SPs) and synthetic transcription factors (STFs) to modulate gene expression. They have greater advantages over the natural ones for their target sequence-specificity, speed, and precise activity. Therefore, manipulation of plant defence regulatory networks by utilizing SPs or STFs represents a new era for synthetically modified crops without negative aspects of the existing biotechnology. This dynamic shift in approach from conventional to modern, transgenic to non-transgenic for manipulating plant defence is discussed in this article, with the aim of their commercial application in crop improvement.
引用
收藏
页码:1598 / 1607
页数:10
相关论文
共 50 条
  • [21] Congenital Heart Disease and Genetic Counseling: Shifting Paradigm
    Sharma, Madhu
    Choueiter, Nadine
    JOURNAL OF PEDIATRICS, 2022, 244 : E6 - E6
  • [22] Chronic Obstructive Pulmonary Disease: Shifting the Paradigm to the Vasculature
    Wouters, Emiel F. M.
    Franssen, Frits M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199 (03) : 258 - 259
  • [23] Targeting Mechanosensitive Transcription Factors in Atherosclerosis
    Niu, Niu
    Xu, Suowen
    Xu, Yanni
    Little, Peter J.
    Jin, Zheng-Gen
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2019, 40 (04) : 253 - 266
  • [24] Transcription Factors and Cancer Approaches to Targeting
    Shiah, Jamie V. V.
    Johnson, Daniel E. E.
    Grandis, Jennifer R. R.
    CANCER JOURNAL, 2023, 29 (01): : 38 - 46
  • [25] Transcription Factors with Targeting Potential in Gliomas
    Giannopoulou, Angeliki-Ioanna
    Kanakoglou, Dimitrios S.
    Piperi, Christina
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (07)
  • [26] Targeting transcription factors for therapeutic benefit
    Brennan, Paul
    Donev, Rossen
    Hewamana, Saman
    MOLECULAR BIOSYSTEMS, 2008, 4 (09) : 909 - 919
  • [27] Selective targeting of transcription factors in neoplasia
    Papavassiliou, A. G.
    ARCHIVES OF HELLENIC MEDICINE, 2013, 30 (01): : 7 - 9
  • [28] Targeting GLI Transcription Factors in Cancer
    Didiasova, Miroslava
    Schaefer, Liliana
    Wygrecka, Malgorzata
    MOLECULES, 2018, 23 (05):
  • [29] Targeting Transcription Factors for Cancer Treatment
    Lambert, Melanie
    Jambon, Samy
    Depauw, Sabine
    David-Cordonnier, Marie-Helene
    MOLECULES, 2018, 23 (06):
  • [30] Targeting transcription factors for cancer therapy
    Redell, MS
    Tweardy, DJ
    CURRENT PHARMACEUTICAL DESIGN, 2005, 11 (22) : 2873 - 2887